Primary prevention of renal failure in diabetic patients: The bergamo nephrologic diabetes complication trial

Journal of Hypertension, Supplement

Volumn 16, Issue 1, 1998, Pages

  Ruggenenti, Piero ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Diabetic nephropathy; Microalbuminuria; Prevention; Trandolapril; Verapamil

Indexed keywords

ALBUMIN; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TRANDOLAPRIL; VERAPAMIL;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; HYPERTENSION; KIDNEY FAILURE; MICROALBUMINURIA; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 0031884211     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
2. Microalbuminuria Collaborative Study Group, United Kingdom. Risk factors for the development of microalbuminuria in insulin dependent diabetic patients: a cohort study. BMJ 1993; 306:1235-1239.
3. Viberti G, Mogensen CE, Groop LC, Pauls JF. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetic patients and microalbuminuria. JAMA 1994; 271:275-279.
4. Ravid M, Lang R, Rachmani R, Lishner M. Long-term renoprotective effect of angiotensin converting enzyme inhibition in non-insulin dependent diabetes mellitus. Arch Intern Med 1996; 156:286-289.
5. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329:1456.